The NetraMark team is excited to release a paper on work they completed with the DWave Quantum Annealer for predicting lung cancer sub-types

November 20, 2018


Here one can access our Whitepaper which reviews the state of drug development and how NetraMark is providing next generation machine learning methods to disrupt this industry. We review patient stratification, deep phenotyping, drug repositioning, and placebo response and how we are addressing these challenges.